Current Issue February 2012, Vol. 102, No. 2

Issue Highlights

Systematic review

Treatment of brain metastases: Review of phase III randomized controlled trials
February 2012(Vol. 102 | No. 2 | Pages 168-179)
Silvia Scoccianti, Umberto Ricardi

Original articles

A pooled analysis of arc-based image-guided simultaneous integrated boost radiation therapy for oligometastatic brain metastases
February 2012(Vol. 102 | No. 2 | Pages 180-186)
George Rodrigues, Wietse Eppinga, Frank Lagerwaard, Patricia de Haan, Cornelis Haasbeek, Francisco Perera, Ben Slotman, Brian Yaremko, Slav Yartsev, Glenn Bauman

Whole-brain irradiation with concomitant daily fixed-dose Temozolomide for brain metastases treatment: A randomised phase II trial
February 2012(Vol. 102 | No. 2 | Pages 187-191)
Carlos Gamboa-Vignolle, Tabaré Ferrari-Carballo, Óscar Arrieta, Alejandro Mohar

Radiographic changes after lung stereotactic ablative radiotherapy (SABR) – Can we distinguish recurrence from fibrosis? A systematic review of the literature
06 February 2012
Kitty Huang, Max Dahele, Suresh Senan, Matthias Guckenberger, George B. Rodrigues, Aaron Ward, R. Gabriel Boldt, David A. Palma
Abstract: Background: Changes in lung density on computed tomography (CT) are common after stereotactic ablative radiotherapy (SABR) and can confound the early detection of recurrence. We performed a ...
Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004–03
02 February 2012
Ivan Toledano, Pierre Graff, Antoine Serre, Pierre Boisselier, René-Jean Bensadoun, Cécile Ortholan, Pascal Pommier, Séverine Racadot, Gilles Calais, Marc Alfonsi, Veronique Favrel, Philippe Giraud, Michel Lapeyre
Abstract: Background and purpose: In 2003, the French Authority for Health (HAS) recommended the use of intensity modulated radiotherapy (IMRT) in prospective trial before its routine use. The Oncolog...
Managing a national radiation oncologist workforce: A workforce planning model
02 February 2012
Teri Stuckless, Michael Milosevic, Catherine de Metz, Matthew Parliament, Brent Tompkins, Michael Brundage
Abstract: Purpose: The specialty of radiation oncology has experienced significant workforce planning challenges in many countries. Our purpose was to develop and validate a workforce-planning model t...
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
02 February 2012
Herbert H. Loong, Brigette B.Y. Ma, Sing-Fai Leung, Frankie Mo, Edwin P. Hui, Michael K. Kam, Stephen L. Chan, Brian K.H. Yu, Anthony T.C. Chan
Abstract: Background and purpose: Concurrent chemoradiotherapy (CRT) confers survival benefit over radiotherapy (RT) alone in the treatment of locoregionally advanced nasopharyngeal carcinoma (NPC). T...
Urinary morbidity after permanent prostate brachytherapy – Impact of dose to the urethra vs. sources placed in close vicinity to the urethra
02 February 2012
Michael Pinkawa, Richard Holy, Marc D. Piroth, Jens Klotz, David Pfister, Axel Heidenreich, Michael J. Eble
Abstract: Background and purpose: The impact of the dose to the urethra and sources placed close to the urethra on urinary morbidity after permanent prostate brachytherapy (PPB) is not well known. Mat...

View More Articles in Press...

1

Article Title	Author(s)	Type	Pages
EORTC-ROG expert opinion: Radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach August 2009 (Vol. 92 \| No. 2 \| Pages 164-175) Abstract Full Text PDF (2033 KB)	Oscar Matzinger, Erich Gerber, Zvi Bernstein, Philippe Maingon, Karin Haustermans, Jean François Bosset, Akos Gulyban, Philip Poortmans, Laurence Collette, Abraham Kuten et al.	Full-length article	164-175
Image guided, adaptive, accelerated, high dose brachytherapy as model for advanced small volume radiotherapy September 2011 (Vol. 100 \| No. 3 \| Pages 333-343) Abstract Full Text PDF (258 KB)	Christine Haie-Meder, Frank-André Siebert, Richard Pötter	Full-length article	333-343
Radiation-induced heart morbidity after adjuvant radiotherapy of early breast cancer – Is it still an issue? August 2011 (Vol. 100 \| No. 2 \| Pages 157-159) Full Text PDF (144 KB)	Birgitte Offersen, Inger Højris, Marie Overgaard	Editorial	157-159
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients July 2009 (Vol. 92 \| No. 1 \| Pages 4-14) Abstract Full Text PDF (478 KB) Supplemental Materials	Jean-Pierre Pignon, Aurélie le Maître, Emilie Maillard, Jean Bourhis, on behalf of the MACH-NC Collaborative Group et al.	Full-length article	4-14
Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention August 2011 (Vol. 100 \| No. 2 \| Pages 160-166) Abstract Full Text PDF (186 KB)	Nicolaus Andratschke, Jean Maurer, Michael Molls, Klaus-Rüdiger Trott	Review article	160-166

1

Most Read lists are compiled every quarter.

Publishing Information

Radiotherapy & Oncology is published by Elsevier.

Click here to read a selection of papers from the launch of Radiotherapy in 1983 to 2011

About Radiotherapy & Oncology

Radiotherapy & Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as physical aspects relevant to oncology, particularly in the field of imaging, dosimetry and radiation therapy planning.

More